Suppr超能文献

跨性别者的生育力保存选择。

Fertility preservation options for transgender individuals.

作者信息

Sterling Joshua, Garcia Maurice M

机构信息

Division of Urology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.

Division of Urology, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA, USA.

出版信息

Transl Androl Urol. 2020 Mar;9(Suppl 2):S215-S226. doi: 10.21037/tau.2019.09.28.

Abstract

Gender affirming medical and surgical treatments affect the reproductive potential of transgender individuals. Prior to the development of assisted reproductive technologies (ART), genital gender-affirming surgery frequently eliminated a patient's reproductive potential. Today, all patients should be counseled on their fertility preservation (FP) options before medical and surgical transition, yet this appears to seldom occur in practice. The following review is the result of a systematic literature search of PubMed, Medline and Google Scholar to identify current and future FP options, barriers to treatment patients face, practice patterns of transgender health care providers, and if there were any standardized counseling protocols. Options for transwomen at any point in their transition range from simply providing a semen sample to be used with assistive reproductive techniques to experimental techniques involving testicular cryopreservation followed by initiation of spermatogenesis. Transmen before and after starting hormone therapy can pursue any assistive reproductive techniques available for ciswomen. Future options currently under investigation include ovarian tissue cryopreservation (OTC) with oocyte maturation. In addition to counseling about their FP options, patients should be advised prospectively about the requirements, process details, the total costs associated with achieving pregnancy, and the inherent risks associated with using preserved genetic material including risk of failure, and maternal and fetal health risks. Transgender patients report using assistive reproductive services difficult, due to a lack of dialogue about fertility and the lack of information offered to them- presumably because their circumstances do not fit into a traditional narrative familiar to providers. Physicians and health care providers would benefit from better to help transgender patients make informed decisions and better about transgender patients in general, and FP options available to them.

摘要

性别肯定性医疗和手术治疗会影响跨性别者的生殖潜能。在辅助生殖技术(ART)发展之前,生殖器性别肯定性手术常常会消除患者的生殖潜能。如今,所有患者在进行医疗和手术转变之前都应接受关于生育力保存(FP)选项的咨询,但在实际中这似乎很少发生。以下综述是对PubMed、Medline和谷歌学术进行系统文献检索的结果,以确定当前和未来的FP选项、患者面临的治疗障碍、跨性别医疗服务提供者的实践模式,以及是否存在任何标准化的咨询方案。跨性别女性在其转变过程中的任何阶段,其选项从简单提供一份精液样本以供辅助生殖技术使用到涉及睾丸冷冻保存然后启动精子发生的实验技术。跨性别男性在开始激素治疗前后都可以采用任何适用于顺性别女性的辅助生殖技术。目前正在研究的未来选项包括卵巢组织冷冻保存(OTC)及卵母细胞成熟。除了就其FP选项进行咨询外,还应前瞻性地告知患者关于实现怀孕的要求、流程细节、相关的总费用,以及使用保存的遗传物质所固有的风险,包括失败风险以及对母婴健康的风险。跨性别患者表示使用辅助生殖服务很困难,原因是缺乏关于生育力的对话以及提供给他们的信息不足——大概是因为他们的情况不符合提供者熟悉的传统模式。医生和医疗服务提供者若能更好地了解情况,将有助于跨性别患者做出明智的决定,并更好地了解一般的跨性别患者以及他们可获得的FP选项。

相似文献

1
Fertility preservation options for transgender individuals.
Transl Androl Urol. 2020 Mar;9(Suppl 2):S215-S226. doi: 10.21037/tau.2019.09.28.
2
Reproductive health in transgender and gender diverse individuals: A narrative review to guide clinical care and international guidelines.
Int J Transgend Health. 2022 Feb 14;24(1):7-25. doi: 10.1080/26895269.2022.2035883. eCollection 2023.
3
Fertility preservation for transgender adolescents and young adults: a systematic review.
Hum Reprod Update. 2019 Nov 5;25(6):694-716. doi: 10.1093/humupd/dmz026.
4
Fertility concerns of the transgender patient.
Transl Androl Urol. 2019 Jun;8(3):209-218. doi: 10.21037/tau.2019.05.09.
5
Fertility preservation options in transgender people: A review.
Rev Endocr Metab Disord. 2018 Sep;19(3):231-242. doi: 10.1007/s11154-018-9462-3.
6
Fertility Considerations in Transgender Persons.
Endocrinol Metab Clin North Am. 2019 Jun;48(2):391-402. doi: 10.1016/j.ecl.2019.02.003. Epub 2019 Mar 23.
7
Factors Affecting Fertility Decision-Making Among Transgender Adolescents and Young Adults.
LGBT Health. 2019 Apr;6(3):107-115. doi: 10.1089/lgbt.2018.0250.
8
Barriers to fertility preservation access in transgender and gender diverse adolescents: a narrative review.
Ther Adv Reprod Health. 2024 Jan 30;18:26334941231222120. doi: 10.1177/26334941231222120. eCollection 2024 Jan-Dec.

引用本文的文献

1
Endocrine Management of Adult Gender-Dysphoric/Gender-Incongruent Persons: A Clinical Practice Guideline from Endocrine Society of India.
Indian J Endocrinol Metab. 2025 Jul-Aug;29(4):366-380. doi: 10.4103/ijem.ijem_144_25. Epub 2025 Aug 26.
4
First Childbirth after Fertility Preservation and Gender Reassigning Surgery from Indian Transgender Community.
J Hum Reprod Sci. 2024 Jul-Sep;17(3):216-220. doi: 10.4103/jhrs.jhrs_49_24. Epub 2024 Sep 26.
5
New Insights on In Vitro Maturation of Oocytes for Fertility Preservation.
Int J Mol Sci. 2024 Oct 1;25(19):10605. doi: 10.3390/ijms251910605.
7
The Most-Cited Publications in Gender-Affirming Surgery: A Cross-Sectional Bibliometric Analysis.
Plast Surg (Oakv). 2024 Feb;32(1):54-63. doi: 10.1177/22925503221088845. Epub 2022 Mar 23.
9
Patients' perspectives on informational needs surrounding gender-affirming vaginoplasty.
Int J Impot Res. 2023 Oct 25. doi: 10.1038/s41443-023-00783-5.

本文引用的文献

1
Perspectives on fertility preservation and parenthood among transgender youth and their parents.
Arch Dis Child. 2019 Aug;104(8):739-744. doi: 10.1136/archdischild-2018-316080. Epub 2019 Mar 20.
2
Fertility preservation options for transgender and gender-nonconforming individuals.
Curr Opin Obstet Gynecol. 2019 Jun;31(3):170-176. doi: 10.1097/GCO.0000000000000537.
3
Knowledge, Practice Behaviors, and Perceived Barriers to Fertility Care Among Providers of Transgender Healthcare.
J Adolesc Health. 2019 Feb;64(2):226-234. doi: 10.1016/j.jadohealth.2018.08.025. Epub 2018 Oct 26.
5
Fertility preservation decision making amongst Australian transgender and non-binary adults.
Reprod Health. 2018 Oct 25;15(1):181. doi: 10.1186/s12978-018-0627-z.
6
Semen Parameters Among Transgender Women With a History of Hormonal Treatment.
Urology. 2019 Feb;124:136-141. doi: 10.1016/j.urology.2018.10.005. Epub 2018 Oct 10.
7
Understudied and Under-Reported: Fertility Issues in Transgender Youth-A Narrative Review.
J Pediatr. 2019 Feb;205:265-271. doi: 10.1016/j.jpeds.2018.09.009. Epub 2018 Oct 4.
8
Fertility preservation options in transgender people: A review.
Rev Endocr Metab Disord. 2018 Sep;19(3):231-242. doi: 10.1007/s11154-018-9462-3.
10
Uterine transplantation in transgender women.
BJOG. 2019 Jan;126(2):152-156. doi: 10.1111/1471-0528.15438. Epub 2018 Sep 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验